Pharmaceutical anti-counterfeiting : (Record no. 18844)

MARC details
000 -LEADER
fixed length control field 05401cam a2200829Ia 4500
001 - CONTROL NUMBER
control field ocn745970855
003 - CONTROL NUMBER IDENTIFIER
control field OCoLC
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20230823095439.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION
fixed length control field m o d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr |n|||||||||
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 101020s2011 njua ob 001 0 eng d
040 ## - CATALOGING SOURCE
Original cataloging agency CDX
Language of cataloging eng
Description conventions pn
Transcribing agency CDX
Modifying agency IDEBK
-- DG1
-- E7B
-- YDXCP
-- N$T
-- OCLCQ
-- MYG
-- OCLCQ
-- OCLCA
-- OCLCF
-- OCLCQ
-- NLGGC
-- OCLCQ
-- DEBSZ
-- MHW
-- UKDOC
-- DEBBG
-- OCLCQ
-- N$T
-- OCLCQ
019 ## -
-- 743204852
-- 746324257
-- 747412618
-- 747427281
-- 791305549
-- 811493653
-- 816850646
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 9781118023679
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 1118023676
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 9781118023655
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 111802365X
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 9781118023662
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 1118023668
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Cancelled/invalid ISBN 9780470616178
Qualifying information (Cloth)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Cancelled/invalid ISBN 0470616172
Qualifying information (Cloth)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Cancelled/invalid ISBN 1283175665
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Cancelled/invalid ISBN 9781283175661
024 8# - OTHER STANDARD IDENTIFIER
Standard number or code 9786613175663
029 1# - (OCLC)
OCLC library identifier AU@
System control number 000049641635
029 1# - (OCLC)
OCLC library identifier DEBBG
System control number BV041911509
029 1# - (OCLC)
OCLC library identifier DEBSZ
System control number 430989806
029 1# - (OCLC)
OCLC library identifier DEBSZ
System control number 449240444
029 1# - (OCLC)
OCLC library identifier NZ1
System control number 14693210
029 1# - (OCLC)
OCLC library identifier SE4M6
System control number 120058359
029 1# - (OCLC)
OCLC library identifier DEBBG
System control number BV043393342
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)745970855
Canceled/invalid control number (OCoLC)743204852
-- (OCoLC)746324257
-- (OCoLC)747412618
-- (OCoLC)747427281
-- (OCoLC)791305549
-- (OCoLC)811493653
-- (OCoLC)816850646
037 ## - SOURCE OF ACQUISITION
Stock number 317566
Source of stock number/acquisition MIL
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number HD9665.5
Item number .D38 2011eb
060 #4 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number QV 773
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 023000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 058170
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 071000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 072000
Source bisacsh
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 615.1068/4
Edition number 22
049 ## - LOCAL HOLDINGS (OCLC)
Holding library MAIN
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Davison, Mark,
Dates associated with a name 1968 March 1-
245 10 - TITLE STATEMENT
Title Pharmaceutical anti-counterfeiting :
Remainder of title combating the real danger from fake drugs /
Statement of responsibility, etc Mark Davison.
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication, distribution, etc Hoboken, N.J. :
Name of publisher, distributor, etc John Wiley & Sons,
Date of publication, distribution, etc ©2011.
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource (xxiii, 402 pages) :
Other physical details illustrations
336 ## -
-- text
-- txt
-- rdacontent
337 ## -
-- computer
-- c
-- rdamedia
338 ## -
-- online resource
-- cr
-- rdacarrier
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references and index.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Frontmatter -- General Themes. Introduction -- Origins and Context of Counterfeiting in Healthcare -- A Snapshot of the Problem -- Risks and Costs of Counterfeit Pharmaceuticals -- Anti-Counterfeiting Definitions -- Protecting and Educating Consumers -- Business Risks and Strategy -- Government Issues -- Intellectual Property and Anti-Counterfeiting -- Traceability or Authentication? -- Authentication. What is Authentication? -- Authentication of the Person -- Authentication of Bulk Products -- On-Dose and In-Dose Authentication -- Analytical Detection of Counterfeit Dosage Forms -- The Role of Packaging -- Printing Technologies -- Security Labels -- Holograms and DOVIDs -- Specialty Inks -- Covert Taggants and Forensic Markers -- General Conclusions on Printed Packaging and Security Labels -- Security of Primary Packaging -- Security of Secondary Packaging -- Analytical Methods for Packaging -- Security of Other Packaging Types -- Bulk Packaging and Transport Security -- Product Tracking. Rationale for Pharmaceutical Tracking -- Tracking Technologies -- Data Format, Generation, and Storage -- Management of Packaging Hierarchy -- Geographical Perspectives -- Product Tracking in Other Industries -- Supply Chain Security Processes -- Implementing Anti-Counterfeiting Initiatives-Practical Issues -- Conclusions and the Future. Where do we go from here? -- New Models, New Approaches -- Selected Examples from around the World -- Further Resources. A Patient's Guide to Avoiding Counterfeit Drugs -- Notes and References -- Glossary -- Further Resources. Information Sources -- Drug Regulators.
520 ## - SUMMARY, ETC.
Summary, etc This book overviews and integrates the business and technical issues that pharmaceutical companies need to know in order to combat the major global problem of counterfeit medicines. In addition to discussion of the problems, the author Davison addresses analytical techniques scientists use to detect counterfeits and presents some possible solutions to the threat of counterfeit medical products. Coverage moves from basic overview of the problem, costs / risks to consumers (toxic products, mistrust of drug companies) and business (revenue loss, public trust), government oversight and regulation, authentication strategies (packaging, analytical techniques), product tracking and supply chain, and case studies from around the globe.
588 0# -
-- Print version record.
526 ## - STUDY PROGRAM INFORMATION NOTE
Department Global Studies and Governance
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Product counterfeiting.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drug adulteration.
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drug Contamination.
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Consumer Product Safety.
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Fraud
General subdivision prevention & control.
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Pharmaceutical Preparations
General subdivision standards.
650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drug adulteration.
650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Product counterfeiting.
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element MEDICAL
General subdivision Drug Guides.
Source of heading or term bisacsh
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element MEDICAL
General subdivision Nursing
-- Pharmacology.
Source of heading or term bisacsh
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element MEDICAL
General subdivision Pharmacology.
Source of heading or term bisacsh
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element MEDICAL
General subdivision Pharmacy.
Source of heading or term bisacsh
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drug adulteration.
Source of heading or term fast
-- (OCoLC)fst00898652
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Product counterfeiting.
Source of heading or term fast
-- (OCoLC)fst01078205
655 #4 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Display text Print version:
International Standard Book Number 9786613175663
Record control number (DLC) 2010044590
-- (OCoLC)671465412
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="http://dx.doi.org/10.1002/9781118023679">http://dx.doi.org/10.1002/9781118023679</a>
Public note Wiley Online Library
994 ## -
-- 92
-- DG1

No items available.